Search Results

Search Results Home

Healthcare

North America Optical Genome Mapping Market By Product (Consumables, Instruments), By Application (Genome Assembly, Structural Variation Detection, Microbial Strain Typing, Haplotype Phasing, Others), By End-User (Research & Academic Institutions, Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Others), By Country, Competition, Forecast & Opportunities, 2020-2030F

Increasing demand for precision medicine and Integration with multi-omics approaches are factors driving the North America Optical Genome Mapping market in the Read More

Asia-Pacific Dental Infection Control Market By Offering (Consumables and Single-Use Products {Cleaning and Sterilization Products, Unit Water-Line Cleaning Management Products, Saliva Ejectors, Others}, Equipment {Cleaning Monitors, Ultrasonic Cleaning Units, Sterilization Equipment}), By End User (Dental Hospitals and Clinics, Dental Academic and Research Institutions, Dental Laboratories), By Country, Competition, Forecast & Opportunities, 2020-2030F

Increasing prevalence of dental infections and other periodontal diseases, is driving the Asia-Pacific Dental Infection Control Market in the forecast period Read More

Asia-Pacific DNA Methylation Detection Technology Market By Technology (Polymerase Chain Reaction, Microarray, Sequencing, Others), By Product (Consumables, Kits & Reagents, Enzymes, Instruments & Software), By End User (Hospital & Diagnostics Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes), By Country, Competition, Forecast & Opportunities, 2020-2030F

The growing research activity in this domain and surge in demand for protein therapeutics, is driving the Asia-Pacific DNA Methylation Detection Technology Read More

Japan Major Depressive Disorder (MDD) Market By Drug Type (Antidepressants, Atypical Antidepressants, Antipsychotics, Neuromodulators, and Others), By Application (Hospitals, Clinics, and Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Advances in antidepressant medications, psychotherapy, and digital health technologies are factors driving the Japan Major Depressive Disorder (MDD) Market in Read More

Japan Epigenetics Market By Product (Reagents, Kits, Instruments, Enzymes and Services), By Technology (DNA Methylation, Histone Methylation, Histone Acetylation, Large non-coding RNA, MicroRNA modification, Chromatin structures), By Application (Oncology, Non-oncology), By End Use (Academic Research, Clinical Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Growing research and advancements in epigenetic mechanisms and escalating prevalence of genetic disorders are factors driving the Japan Epigenetics Market in the Read More

Japan Blood Plasma Market, By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Others), By Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, Others), By End User (Hospitals, Clinics, Others), By Region, Competition Forecast & Opportunities, 2020-2030F

Increasing Prevalence of Blood Disorders and Advancements in Plasma-Based Therapies are factors driving the Japan Blood Plasma market in the forecast period Read More

Japan Burn Care Market, By Burn Type (Thermal Burn, Electrical Burn, Chemical Burn, Radiation Burn, Friction Burn, Others), By Product Type (Advanced Burn Care, Biologics, Traditional Burn Care, Other), By Route of Administration (Oral, Parenteral, Others), By End User (Hospitals, Specialty Clinics, Others), By Distribution Channel (Online, Offline), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rising Incidence of Burn Injuries and Increased Awareness and Preventive Measures are factors driving the Japan Burn Care market in the forecast period 2026-2030.Read More

Asia-Pacific Protein Expression Market By Application (Biopharmaceutical Manufacturing, Research and Development, Industrial Usage), By Product (Kits and Reagents, Expression Vectors, Competent Cells, Plastic Consumables and Accessories), By End User (Biopharmaceutical and Biotech Companies, CRO and CDMO, Academic & Research Institutes, Others), By Country, Competition, Forecast & Opportunities, 2020-2030F

The growing research activity in this domain and surge in demand for protein therapeutics, is driving the Asia-Pacific Protein Expression Market in the forecast Read More

Japan Vision Care Market, By Product (Eyeglasses, Contact Lens, Intraocular Lens, Others), By Type (Rx (Prescription), Non-Rx (Non-Prescription), By Indication (Refractive Error, Glaucoma, Diabetic Retinopathy, Amblyopia, Dry Eyes, Others), By Treatment (Surgery, Laser Therapy, Medication, Others), By End User (Eye Hospitals and Clinics, Ambulatory Surgery Center, Optical Stores, Others), By Distribution Channel (Retail Stores, E-Commerce, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rising Prevalence of Vision Disorders and Technological Advancements are factors driving the Japan Vision Care Market in the forecast period 2026-2030.Read More

Japan Cell Based Immunotherapy Market, By Therapy (Autologous Cellular Immunotherapy, Chimeric Antigen Receptor (CAR) T-Cell Therapy, Dendritic Cell-based Vaccine Therapy), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Other), By Region, Competition Forecast & Opportunities, 2020-2030F

Rising Incidence of Cancer and Advancements in Cellular Technology are factors driving the Japan Cell Based Immunotherapy market in the forecast period 2026-2030Read More

Japan Glaucoma Drugs Market By Indication (Open Angle Glaucoma, Angle Closure Glaucoma, Others), By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region, Competition, Forecast & Opportunities, 2020-2030F

Increased prevalence of glaucoma, and advancements in drug therapies are factors driving the Japan Glaucoma Drugs Market in the forecast period 2026-2030.Read More

Japan Gastrointestinal Drugs Market By Type (Branded and Generics), By Drug Class (Aminosalicylates, Digestive enzymes, Proton Pump Inhibitors, Laxatives, Anti-Emetics, H2 Antagonists, Anti-Diarrheal, Biologics/Biosimilar, and Others), By Application (Crohn’s Disease, Ulcerative Colitis, GERD, IBS), By Route Of Administration (Oral, Injectable, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Increasing availability and acceptance of over-the-counter (OTC) gastrointestinal medications are factors driving the Japan Gastrointestinal Drugs Market in the Read More

Japan Cough Remedies Market, By Type (Expectorants, Antihistamines, Bronchodilators, Antibiotics, Others), By Dosage Form (Oral syrup, Tablets/pills, Lozenges, Others), By Distribution Channel (Retail, Online pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Increasing Incidence of Respiratory Conditions and Aging Population are factors driving the Japan Cough Remedies market in the forecast period 2026-2030.Read More

Japan Brain Cancer Therapeutics Market, By Type (Gliomas, Meningiomas, Pituitary Adenomas, Vestibular Schwannomas, Neuroectodermal Tumours), By Treatment (Chemotherapy, Immunotherapy, Targeted Drug Therapy, Radiation Therapy, Others), By End User (Hospitals, Oncology Specialty Clinics, Oncology Treatment Centres, Others), By Region, Competition Forecast & Opportunities, 2020-2030F

Increasing Incidence of Brain Cancer and Advancements in Treatment Technologies are factors driving the Japan Brain Cancer Therapeutics market in the forecast Read More

Japan Gynecology Drugs Market By Therapeutics (Hormonal Therapy and Non-Hormonal Therapy), By Indication (Gynecology Cancers, Menopausal Disorder, Polycystic Ovary Syndrome, Contraception, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Expansion of distribution channels and increasing prevalence of gynecological disorders are factors driving the Japan Gynecology Drugs Market in the forecast Read More

Japan Haematology Market By Product (Hematology Analyzers, Flow Cytometers, Coagulation Analyzers, Slide Stainers, Centrifuges, Hemoglobinometers, and Others), By Reagents (Coagulation Reagents, Flow Cytometry Reagents, Immuno-haematology Reagents, and Others), By Application (Drug Testing, Auto-immune Diseases, Cancer, Diabetes Mellitus, Infectious Diseases, and Others), By End User (Hospitals, Clinical Testing Institutes, Patient Self-testing, and Other End Users), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rapid advancement in diagnostic technologies and growing prevalence of hematological disorders are factors driving the Japan Haematology Market in the forecast Read More

Japan Hematopoietic Stem Cell Transplantation Market By Therapy (Allogenic, Autologous), By Indication (Lymphoproliferative Disorder, Leukemia, Non-Hodgkin lymphoma, Hodgkin lymphoma, Plasma cell disorders and Others), By Application (Bone Marrow Stem Cell Transplant, Peripheral blood stem cell transplant, and Cord blood transplant), By End User (Hospitals, Specialty Clinics, and Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rising incidence of hematological disorders and technological advancements in stem cell therapies are factors driving the Japan Hematopoietic Stem Cell Read More

Japan Human Insulin Market By Product Type (Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin, Biosimilars), By Application (Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus), By Type (Human Insulin, Insulin Analog), By Distribution Channel (Hospitals, Retail Pharmacies, and Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rising prevalence of diabetes and development of innovative insulin formulations are factors driving the Japan Human Insulin Market in the forecast period Read More

Japan Kidney Cancer Drugs Market By Therapy (Immunotherapy, Chemotherapy, Targeted Therapy), By Drug Class (Monoclonal antibodies, Angiogenesis and mTOR Inhibitors), By Route of Administration (Oral, Intravenous and Subcutaneous), By Distribution Channel (Hospitals, Retail Pharmacies, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rising incidence of renal cell carcinoma (RCC) and advancements in targeted therapies & immunotherapies are factors driving the Japan Kidney Cancer Drugs Market Read More

Japan Lipid Lowering Drugs Market, By Drug (Statins & Combination, PCSK9 Inhibitors, Bile Acid Sequestrants, Fibrates, Cholesterol Absorption Inhibitors, Others), By Indication (Hypercholesterolemia, Coronary Artery Disease, High Triglycerides), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Advancements in pharmaceutical research and increasing prevalence of cardiovascular diseases are factors driving the Japan Lipid Lowering Drugs Market in the Read More

Prev    Page 159 of 207 Next

Categories

Countries